0000105770-26-000041
SEC filingWest Pharmaceutical Services, Inc. filed a Form 8-K on March 9, 2026, disclosing matters under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, and furnishing a press release as Exhibit 99.1 under Item 7.01 and Item 9.01. These disclosures may impact executive leadership and governance stability for investors.